Natural History Study of Patients With Hypophosphatasia (HPP)

NCT ID: NCT02237625

Last Updated: 2025-03-14

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 200 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-09-30
• Study Completion Date: 2028-09-30

Brief Summary

Hypophosphatasia (HPP) is a rare inherited metabolic disorder characterized by defective bone and teeth mineralization caused by mutations of the ALPL gene, which encodes for the tissue-nonspecific alkaline phosphatase (TNSALP) isozyme, resulting in decreased serum and bone alkaline phosphatase levels. To date, over 250 different mutations in the gene encoding TNSALP have been associated with HPP. Clinically, the loss of TNSALP function results in progressive skeletal impact as well as progressive impact on all other major organ systems. It clinically manifests as rickets in infants and children and osteomalacia at all ages. The severe form of the disease has been estimated to have a prevalence of about 1 in every 100,000 live births.

Detailed Description

Inheritance can be autosomal recessive or dominant, and penetrance is variable resulting in a wide range of clinical expressivity, with a spectrum ranging from stillbirth without mineralized bone to early loss of teeth without bone symptoms. Depending on the age at diagnosis six clinical forms are currently recognized: perinatal (lethal), perinatal benign, infantile, childhood, adult and odontohypophosphatasia. Severe forms of HPP (perinatal and infantile) are inherited as an autosomal recessive trait and in milder forms (adult and odontohypophosphatasia) autosomal recessive and autosomal dominant inheritance coexist.

Because of the rarity of HPP as well as the side spectrum of both clinical presentation and inheritance patterns of the HPP trait, a natural history study cataloging specific clinical data with HPP would prove invaluable for future research into this disease. Specifically, it is our goal to create a comprehensive multi-discipline modality for care for hypophosphatasia patients, researching clinical manifestations of the disease such as extent of bone disease, ophthalmologic manifestations, orthopedic issues, renal issues, musculoskeletal manifestations as well as other more anecdotal findings such as those seen with cochlear implant failures and/or early menopause.

Conditions

Hypophosphatasia

Study Design

• Observational Model Type: FAMILY_BASED
• Study Time Perspective: PROSPECTIVE

Study Groups

Medical History of HPP Patients

Patient clinical data will be collected related to the diagnosis, onset, progression, treatment course and outcome for patients with HPP.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Patients or their legal representative must provide written informed consent or, if applicable, qualify for waiver of consent.
• Patients must have a pre-established clinical diagnosis of HPP, as indicated by one or more of the following:

• Serum alkaline phosphatase (ALP) below the age-adjusted normal range
• Plasma PLP at least twice the upper limit of normal (no vitamin B6 administered for at least 1 week prior to determination)
• Evidence of osteopenia or osteomalacia on skeletal radiographs
• Genetic analysis fof the ALPL gene
• Must be current patient in the Duke University System.

Exclusion Criteria

• Any patient without confirmation of clinical diagnosis of HPP.

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Duke University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Priya Kishnani, MD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Duke University Medical Center

Durham, North Carolina, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Janet G Blount, BA

Role: CONTACT

janet.blount@duke.edu

919-681-7962

Facility Contacts

Priya Kishnani, MD

Role: primary

kishn001@mc.duke.edu

919-681-1939

Stephanie DeArmey, PA-C

Role: backup

dearm001@mc.duke.edu

(919) 681-1946

Other Identifiers

Pro00049204

Identifier Type: OTHER

Identifier Source: secondary_id

Pro00049204

Identifier Type: -

Identifier Source: org_study_id